We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
SELLAS is a privately held, oncology-focused, clinical stage biopharmaceutical company.
The newly formed company will feature a late-stage pipeline focusing on the development of new immunotherapies targeting a wide range of indications in haematology an